Krill oil and Afinitor drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Krill oil (krill oil) and Afinitor (everolimus). Common drug interactions include rash among females and back pain among males.
The phase IV clinical study analyzes what interactions people have when they take Krill oil and Afinitor. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Krill oil?
Krill oil has active ingredients of krill oil. It is often used in high blood cholesterol. eHealthMe is studying from 5,042 Krill oil users. Check the latest studies of Krill oil.
What is Afinitor?
Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 41,680 Afinitor users. Check the latest studies of Afinitor.
12 people who take Krill oil and Afinitor together, and have interactions are studied.

What are the common drug interactions of Krill Oil and Afinitor, by gender? *:
female:
- Rash
- Peripheral swelling
- Fall
- Hyperglycaemia (high blood sugar)
- Nausea (feeling of having an urge to vomit)
- Arthralgia (joint pain)
- Dry skin
- Erythema (redness of the skin)
- Mouth ulceration (mouth ulcers)
- Nail infection
male:
- Back pain
- Cough
- Gait disturbance
- Renal cancer metastatic (cancer of kidney spreads to other part)
- Abdominal discomfort
- Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
- Arthralgia (joint pain)
- Breath sounds
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Dehydration (dryness resulting from the removal of water)
What are the common drug interactions of Krill Oil and Afinitor, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Abdominal discomfort
- Arthralgia (joint pain)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Dry mouth
- Dry skin
- Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
- Hypertension (high blood pressure)
- Malaise (a feeling of general discomfort or uneasiness)
50-59:
- Fall
- Hyperglycaemia (high blood sugar)
- Nausea (feeling of having an urge to vomit)
- Rash
- Blood sodium decreased
- Blood urine present
- Bone cyst
- Dehydration (dryness resulting from the removal of water)
- Ephelides (tanned macules found on the skin)
- Hair disorder
60+:
- Back pain
- Cough
- Gait disturbance
- Renal cancer metastatic (cancer of kidney spreads to other part)
- Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
- Arthralgia (joint pain)
- Breath sounds
- Drug intolerance (drug sensitivity)
- Hypotension (abnormally low blood pressure)
- Lumbar radiculopathy (radicular pain in the low back and legs)
What are the existing conditions these people have? *
- Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 16.67%
- Angiomyolipoma (most common benign tumour of the kidney): 2 people, 16.67%
- Renal Cell Carcinoma (a kidney cancer): 1 person, 8.33%
- Renal Cancer Metastatic (cancer of kidney spreads to other part): 1 person, 8.33%
- Oedema (fluid collection in tissue): 1 person, 8.33%
- Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 1 person, 8.33%
- Neoplasm Progression (growth of tumour): 1 person, 8.33%
- Nausea (feeling of having an urge to vomit): 1 person, 8.33%
- Breast Cancer Female: 1 person, 8.33%
- Breast Cancer: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Krill oil and Afinitor?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Krill oil and Afinitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Krill oil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Afinitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Krill oil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Afinitor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on krill oil and everolimus (the active ingredients of Krill oil and Afinitor, respectively), and Krill oil and Afinitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Breo Ellipta and Appetite Decreased for Men aged 40-49 - now
- Breo Ellipta and Reduced Appetite for Men aged 40-49 - a second ago
- Breo Ellipta and Loss Of Appetite for Men aged 40-49 - a second ago
- Breo Ellipta and Decreased Appetite for Men aged 40-49 - a second ago
- Breo Ellipta and Appetite - Decreased for Men aged 40-49 - a second ago
- Drug interactions of Valacyclovir Hydrochloride and Xeljanz Xr - 7 seconds ago
- Synthroid and Faeces Discoloured for Women aged 60+ - 11 seconds ago
- Synthroid and Faeces Discolored for Women aged 60+ - 11 seconds ago
- Depo-Testosterone and Not Effective for Men aged 40-49 - 13 seconds ago
- Depo-Testosterone and Drug Ineffective for Men aged 40-49 - 14 seconds ago